Back to search
FDAFDA · Food and drugs·Recall number Z-2152-2014

VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma.

Published August 13, 2014 · Recall initiated: October 14, 2013

Summary

FDA records medical device Class II recall Z-2152-2014, published August 13, 2014 and initiated October 14, 2013. Recalling firm: BioMerieux SA; Status: Terminated; Reported quantity: 1902; Lot: Lot 1001904130. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product is not approved or authorized for distribution in the US.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioMerieux SA
Distributor
FL, LA, MI, MS, NV, OH, OK, TN, TX
Lot
Lot 1001904130
Risk classification
Class II
Area (FDA)
device
Country
France

Related recalls

Questions about this recall

Was VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific antigen levels in human serum or plasma. recalled?

Yes. FDA published recall Z-2152-2014 on August 13, 2014. Reported hazard: Product is not approved or authorized for distribution in the US.

What should I do if I have this product?

Voluntary: Firm initiated · Letter